Literature DB >> 19731260

Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer.

Tomoyoshi Takenaka1, Tokujiro Yano, Kensaku Ito, Yousuke Morodomi, Naoko Miura, Daigo Kawano, Fumihiro Shoji, Koichiro Abe, Hiroshi Honda, Yoshihiko Maehara.   

Abstract

BACKGROUND: The 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) has recently become an important non-invasive tool for the diagnosis and staging in several cancers. The standardized uptake value (SUV) of primary tumor has been reported to relate to cancer progression and prognosis, however, biological mechanism is still unclear.
METHOD: Seventy-nine patients with non-small cell lung cancer (NSCLC) who had undergone preoperative FDG-PET and a surgical resection were enrolled in this study. NSCLC tissue samples prepared from the surgical specimens were subjected to an immunohistochemical analysis for the expression of Ki-67 and vascular endothelial growth factor (VEGF) proteins. The relationships between the expression status of these proteins and SUV(max) of primary tumors were evaluated. RESULT: Concerning the relationship with various clinicopathological findings, SUV(max) of primary tumors was associated with histology, tumor proliferation, pleural or vascular invasion, and pathological stage. A significant correlation was observed between the SUV(max) and either the Ki-67 or VEGF expression (P < 0.001, P = 0.006), respectively. Cases with both Ki-67-negative and VEGF-negative findings exhibited a significantly lower SUV(max) than those with single positive or double positive cases (P = 0.006, P < 0.001).
CONCLUSION: The SUV(max) was associated with the expression of Ki-67 and VEGF in NSCLC. These findings indicated that the SUV(max) of primary tumors might therefore reflect the biological malignant potential in NSCLC. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19731260     DOI: 10.1002/jso.21386

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Authors:  Kyuichi Kadota; Christos Colovos; Kei Suzuki; Nabil P Rizk; Mark P S Dunphy; Emily C Zabor; Camelia S Sima; Akihiko Yoshizawa; William D Travis; Valerie W Rusch; Prasad S Adusumilli
Journal:  Ann Surg Oncol       Date:  2012-05-30       Impact factor: 5.344

2.  High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.

Authors:  Kyuichi Kadota; Stefan S Kachala; Jun-Ichi Nitadori; Kei Suzuki; Mark P S Dunphy; Camelia S Sima; William D Travis; Valerie W Rusch; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2012-07       Impact factor: 15.609

3.  Predictive value of intratumor metabolic and heterogeneity parameters on [18F]FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma.

Authors:  Ming Ni; Shicun Wang; Xin Liu; Qin Shi; Xingxing Zhu; Yifan Zhang; Qiang Xie; Weifu Lv
Journal:  Jpn J Radiol       Date:  2022-10-11       Impact factor: 2.701

4.  Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China.

Authors:  Xiaoyan Sun; Tianxiang Chen; Chun Xie; Liu Liu; Bei Lei; Lihua Wang; Maomei Ruan; Hui Yan; Qi Zhang; Cheng Chang; Wenhui Xie
Journal:  BMJ Open       Date:  2022-05-17       Impact factor: 3.006

5.  Investigating the association between ground-glass nodules glucose metabolism and the invasive growth pattern of early lung adenocarcinoma.

Authors:  Xiaoliang Shao; Xiaonan Shao; Rong Niu; Zhenxing Jiang; Mei Xu; Yuetao Wang
Journal:  Quant Imaging Med Surg       Date:  2021-08

6.  Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.

Authors:  Sheng-Ming Deng; Wei Zhang; Bin Zhang; Yin-Yin Chen; Ji-Hui Li; Yi-Wei Wu
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

7.  Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.

Authors:  Kewei Zhao; Chunsheng Wang; Fang Shi; Yong Huang; Li Ma; Minghuan Li; Yipeng Song
Journal:  BMC Cancer       Date:  2021-01-14       Impact factor: 4.430

8.  Risk factors of chest wall invasion in non-small cell lung cancer.

Authors:  Nozomu Motono; Shun Iwai; Aika Yamagata; Yoshihito Iijima; Katsuo Usuda; Sohsuke Yamada; Hidetaka Uramoto
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

9.  Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to tumour size and histology.

Authors:  Luca Brunese; Barbara Greco; Francesca Rosa Setola; Francesco Lassandro; Mario Rosario Guarracino; Marialiusa De Rimini; Sergio Piccolo; Nicolina De Rosa; Roberto Muto; Andrea Bianco; Pietro Muto; Roberto Grassi; Antonio Rotondo
Journal:  Med Sci Monit       Date:  2013-02-07

Review 10.  A review on immunohistochemical and histopathologic validation in PET-CT findings with consideration to microRNAs.

Authors:  Marius-Ioan Bădan; Eduard-Alexandru Bonci; Doina Piciu
Journal:  Med Pharm Rep       Date:  2019-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.